Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2350-2353

  Souza, Rhonda F ^a   Yin, Jing ^a   Smolinski, Kara N ^a   Zou, Tong Tong ^a   Wang, Suna ^a   Shi, Ying Qiang ^a   Rhyu, Mun Gan ^b   Cottrell, John ^a   Abraham, John M ^a   Biden, Kelli ^c   Simms, Lisa ^c   Leggett, Barbara ^c   Bova, G Steven ^d   Frank, Tom ^e   Powell, Steven M ^f   Sugimura, Haruhiko ^g   Young, Joanne ^c   Harpaz, Noam ^h   Shimizu, Kenji ⁱ   Matsubara, Nagahide ⁱ   Meltzer, Stephen J ^a   more..

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Mt Sinai Liver Cancer Program   (United States)

ⁱ OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; NERVE CELL ADHESION MOLECULE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRINUCLEOTIDE;

ARTICLE; CELL CYCLE; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA REPAIR; ENDOMETRIUM CANCER; GASTROINTESTINAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH ADENOCARCINOMA; TRINUCLEOTIDE REPEAT; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADENOCARCINOMA; ALLELES; BETA CATENIN; CADHERINS; CHROMOSOME DELETION; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; DNA-BINDING PROTEINS; E2F4 TRANSCRIPTION FACTOR; ENDOMETRIAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HETEROZYGOTE; HUMANS; MALE; MUTATION; PROSTATIC NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 14444280359     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. La Thangue, N. B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci., 19: 108-114, 1994
2. Adams P, D., and Kaelin, W. G., Jr. Transcriptional control by E2F. Semin. Cancer Biol., 6: 99-108, 1995.
3. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
4. Qin, X. Q., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
5. Shan, B., and Lee, W. H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
6. Wu, X., and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
7. Kowalik, T. F., DeGregori, J., Schwarz, J. K., and Nevins, J. R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol., 69: 2491-2500, 1995.
8. Krek, W., Xu, G., and Livingston, D. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83: 1149-1158, 1995.
9. Sardat, C., Vidai, M., Cobrinik, C., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA, 92: 2403-2407, 1995.
10. Hiebert, S. W., Lipp, M., and Nevins, J. R. E1A-dependent trans-activation of the human MYC promoter is mediated by the R2F factor. Proc. Natl. Acad. Sci. USA, 86: 3594-3598, 1989.
11. Thalmeier, K., Synovzik, H., Mertz, R., Winnacker, E-L., and Lipp, M. Nuclear factor E2F mediates basic transcription and trans-activation by E1A of the human MYC promoter. Genes Dev., 3: 527-536, 1989.
12. Pearson, B. E., Nasheuer, H. P., and Wang, T. S. F. Human DNA polymerase α gene, sequences controlling expression in cycling and serum-stimulated cells. Mol. Cell. Biol., 11: 2081-2095, 1991.
13. Vairo, G., Livingston, D. M., and Ginsberg, D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev., 9: 869-881, 1995.
14. Phillip, A., Schneider, A., Vasrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., and Eilers, M. Repression of cyclin D1 : a novel function of MYC. Mol. Cell. Biol., 14: 4032-4043, 1994.
15. Herber, B., Truss, M., Beato, M., and Muller, R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene, 9: 1295-1304, 1994.
16. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z-X., Xu, G., Wydner, K. L., DeCaprio, J. A., Lawrence, J. B., and Livingston, D. M E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev., 8: 2665-2679, 1994.
17. Vairo, G., Livingston, D. M., and Ginsberg, D. Functional interaction between H2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma family members. Genes Dev., 9: 869-881, 1995.
18. Meltzer, S. J., Yin, J., Manin, B., Rhyu, M-G., Cottrell, J., Hudson, E., Redd, J. L., Krasna, M. J., Abraham, J. M., and Reid, B. J. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinoma. Cancer Res., 54: 3379-3382, 1994.
19. Suzuki, H., Harpaz, N., Tarmin, L., Yin, J., Jiang, H-Y., Bell, J. D., Hontanosas, M., Groisman, G. M., Abraham, J. M., and Meltzer, S. J. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res., 54: 4841-4844, 1994.
20. Rhyu, M-G., Park, W-S., and Meltzer, S. J. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene, 9: 29-32, 1994.
21. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
22. Peltomäki, P., Aaltonen, L. A., Sistonen, P., Pylkkänen, L., Mecklin, J-P., Jarvinen, H., Green, J. S., Jass, J. R., Weber, J. L., Leach, F. S., Petersen, G. M., Hamilton, S. R., de la Chapelle, A., and Vogelstein, B. Genetic mapping of a locus predisposing to human colorectal cancer. Science (Washington DC), 260: 810-812, 1993.
23. Aaltonen, L. A., Peltomäki, P., Leach, F. S. Sistonen, P., Pylkkänen, L., Mecklin, J-P., Jarvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., Kinzler, K. W., Vogelstein, B., and de la Chapelle, A. Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC,) 260; 812-816, 1993.
24. Thibodeau, S. N., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816-819, 1993.
25. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Wilson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1333, 1995.
26. Parsons, R., Myeroff, L. L., Liu, B., Wilson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor-β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
27. Myeroff, L. L, Parson, R., Kim, S-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y-J., Lee, H Y., Park, J-G., Lynch, H. T., Roberts, A. B., Vogelstein, B., and Markowitz, S. D. Transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
28. Souza, R. F., Lei, J., Yin, J., Appel, R., Zou, T-T., Zhou, X., Wang, S., Rhyu, M-G., Cymes, K., Chan, O., Park, W-S., Krasna, M., Greenwald, B. D., Cottrell, J., Abraham, J. M., Simms, L., Leggett, B., Young, J., Harpaz, N., and Meltzer, S. J. A transforming growth factor-β1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology. 112: 40-45, 1997.
29. Souza, R. F., Appel, R., Yin, J., Wang, S., Smolinski, K. N., Abraham, J. M., Zou, T-T., Shi, Y-Q., Lei, J., Cottrell, J., Cymes, K., Simms, L., Leggett, B., Lynch, P. M., Frazier, M., Powell, S. M., Harpaz, N., Sugimura, H., Young, J., and Meltzer, S. J. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors. Nat. Genet., 14: 255-257, 1996.
30. Boynton, R. F., Huang, Y., Blount, P. L., Reid, B. J., Raskind, W. H., Haggitt, R. C., Newkirk, C., Resau, J. H., Yin, J., McDanie, I T., and Meltzer, S. J. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res., 51: 5766-5769, 1991.
31. Mäkelä, T. P., Hellsten, K., Vesa, J., Alitalo, K., and Peltonen, L., An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. Hum. Mol. Genet., 1: 217, 1992.
32. Perry, D. J. Trinucleotide repeat polymorphism in the human antithrombin III (AT3) gene. Hum. Mol. Genet., 2: 618, 1993.
33. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., and Lathrop, M. A second-generation linkage map of the human genome. Nature (Lond.), 359: 794-801, 1992.
34. Nishimura, D. Y., and Murray, J. C. A tetranucleotide repeat for the F13B locus. Nucleic Acids Res., 20: 1167, 1992.
35. Simms, L., Zou, T-T., Shi, Y-Q., Lei, J., Appel, R., Souza, R. F., Meltzer, S. J., and Leggett, B. A. Apparent protection from instability of repeat sequences in cancer related genes in replication error positive gastrointestinal cancers. Oncogene, in press, 1997.
36. Yoshitaka, T., Nagahide, M., Ikeda, M., Tanino, M., Hanafusa, H., Tanaka, N., and Shimizu, K. Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem. Biophys. Res. Commun. 227: 553-557, 1996.
37. Weinberg, R. A. E2F and cell proliferation: a world turned upside down. Cell. 85: 457-459, 1996.
38. Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., and Helin, K. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol., 13: 7813-7825, 1993.
39. Helin, K., Lees, J. A., Vidai, M., Dyson, N., Harlow, E., and Fattaey, A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 70: 337-350, 1992.
40. Yamasaki, L., Jack, T., Bronson, R., Goillot, G., Harlow, E., and Dyson, N. J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85: 537-548, 1996.
41. Field, S. J., Tsai, F-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., and Greenberg, M. E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85: 549-561, 1996.
42. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., and Friend, S. H. Germ line mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
43. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (Lond.), 348: 747-749, 1990.
44. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
45. Lee, E. Y-H. P., Chang, C-Y., Hu, N., Wang, Y-C. J., Lai, C-C., Herrup, K., Lee, W-H., and Bradley, A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (Lond.), 359: 288-294, 1992.
46. Knudson, A. G., Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
47. Malkhosyan, S., Rampino, N., Yamamoto, H., and Perucho, M. Frameshift mutator mutations. Nature (Lond.), 382: 499-50, 1996.